S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.05%) $0.927
USD/NOK
(0.18%) $10.86
USD/GBP
(0.02%) $0.792
USD/RUB
(-0.16%) $92.43

Realtime updates for Pharmiva AB (publ) [PHARM.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated17 Nov 2023 @ 11:32

-16.17% SEK 0.560

Live Chart Being Loaded With Signals

Commentary (17 Nov 2023 @ 11:32):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Pharmiva AB (publ) engages in the research and development of medical products. The company develops Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis...

Stats
Today's Volume 66 963.00
Average Volume 19 584.00
Market Cap 12.93M
EPS SEK-0.348 ( 2023-06-30 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.427
ATR14 SEK0.0630 (11.25%)

Volume Correlation

Long: -0.04 (neutral)
Short: -0.41 (neutral)
Signal:(37.795) Neutral

Pharmiva AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pharmiva AB (publ) Correlation - Currency/Commodity

The country flag 0.07
( neutral )
The country flag 0.35
( neutral )
The country flag 0.00
( neutral )
The country flag 0.13
( neutral )
The country flag 0.60
( weak )
The country flag -0.02
( neutral )

Pharmiva AB (publ) Financials

Annual 2022
Revenue: SEK2.63M
Gross Profit: SEK2.59M (98.40 %)
EPS: SEK-1.360
Q2 2023
Revenue: SEK897 000
Gross Profit: SEK587 000 (65.44 %)
EPS: SEK-0.350
Q1 2023
Revenue: SEK1.08M
Gross Profit: SEK710 000 (65.56 %)
EPS: SEK-0.310
Q4 2022
Revenue: SEK1.06M
Gross Profit: SEK890 000 (84.36 %)
EPS: SEK-0.360

Financial Reports:

No articles found.

Pharmiva AB (publ)

Pharmiva AB (publ) engages in the research and development of medical products. The company develops Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. The company is based in Lund, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators